Skip to main content

Addressing the Impact of Tobacco and Alcohol Use on Cancer-Related Health Outcomes: A Workshop

In progress

Any project, supported or not by a committee, that is currently being worked on or is considered active, and will have an end date.

On March 17 and 18, 2025, a planning committee of the National Academies of Sciences, Engineering, and Medicine will host a public workshop that will explore strategies to reduce tobacco and alcohol use to lower cancer risk and improve health outcomes.

Description

A National Academies of Sciences, Engineering, and Medicine planning committee will organize and host a 1.5-day public workshop that will explore strategies to reduce tobacco and alcohol use to lower cancer risk and improve health outcomes. The workshop will feature invited presentations and panel discussions on topics that may include:

  • The effects of tobacco and alcohol use--including synergistic effects--on cancer incidence and outcomes.
  • Risk factors for tobacco and alcohol use and their influence on differences in outcomes.
  • Clinical practice guidelines, including in the context of cancer treatment, for tobacco cessation and interventions to help patients reduce alcohol use.
  • Strategies for data collection and research to address evidence gaps.
  • Lessons from tobacco control that could be applied to encourage reduction in alcohol use.
  • Impact of recent tobacco policy changes and ways to further advance progress in tobacco control.

The planning committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.

Collaborators

Sponsors

American Association for Cancer Research

American Cancer Society

American College of Radiology

American Society of Clinical Oncology

Association of American Cancer Institutes

Association of Community Cancer Centers

Bristol Myers Squibb

Cancer Support Community

Centers for Disease Control and Prevention

Flatiron Health

Merck

National Cancer Institute

National Comprehensive Cancer Network

National Institutes of Health

National Patient Advocate Foundation

Novartis Oncology

Oncology Nursing Society

Partners In Health

Pfizer Inc.

Sanofi

Society for Immunotherapy of Cancer

Staff

Francis Amankwah

Lead

FAmankwah@nas.edu

Sharyl Nass

Lead

SNass@nas.edu

Emma Wickland

EWickland@nas.edu

Jennifer Zhu

JZhu@nas.edu

Makeda Haughton

MHaughton@nas.edu

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.